The phase 3 NRG Oncology GU005 trial of SBRT vs MH-IMRT for intermediate-risk prostate cancer had co-primary endpoints including disease control and patient-reported outcomes.

PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...

NORFOLK, Va. — Prostate cancer is the second-most deadly cancer among men in the United States. Rates are rising and experts are not sure why. But there is good news: when detected early, prostate ...

Prostate cancer incidence is increasing, especially in advanced stages, reversing previous declines and slowing mortality rate improvements. Racial disparities persist, with Black and Native American ...

Dr. Kalnicki answers the question: 'Is Prostate Surgery Done After Radiation?' March 16, 2009 -- Question: Can I have prostate surgery if my radiation treatments are unsuccessful? Answer: Prostate ...

In India, awareness about prostate cancer remains alarmingly low, with many men avoiding screenings altogether and dismissing early warning signs until the disease has progressed. This reluctance ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer. Adding the drug enzalutamide to standard hormone therapy reduced the risk of ...

The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. Stereotactic body radiation therapy (SBRT) preserves ...